These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35932386)

  • 1. An open-label, crossover study to compare different formulations and evaluate effect of food on pharmacokinetics of pimitespib in patients with advanced solid tumors.
    Komatsu Y; Shimokawa T; Akiyoshi K; Karayama M; Shimomura A; Kawamoto Y; Yuki S; Tambo Y; Kasahara K
    Invest New Drugs; 2022 Oct; 40(5):1011-1020. PubMed ID: 35932386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of posaconazole (a strong CYP3A4 inhibitor), two new tablet formulations, and food on the pharmacokinetics of idasanutlin, an MDM2 antagonist, in patients with advanced solid tumors.
    Nemunaitis J; Young A; Ejadi S; Miller W; Chen LC; Nichols G; Blotner S; Vazvaei F; Zhi J; Razak A
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):529-537. PubMed ID: 29368050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of Morphine Sulfate Orodispersible Tablets and Bioequivalence with Immediate-Release Oral Morphine Sulfate Formulations in Healthy Adult Subjects Under Fasting Conditions: Single-Dose Comparative Bioavailability Studies.
    Atrux-Tallau N; Naimi Z; Jaudinot EO
    Clin Drug Investig; 2022 Dec; 42(12):1101-1112. PubMed ID: 36331670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Bioequivalence of Two Peficitinib Formulations, and the Effect of Food on the Pharmacokinetics of Peficitinib: Two-Way Crossover Studies of a Single Dose of 150 mg Peficitinib in Healthy Volunteers.
    Shibata M; Toyoshima J; Kaneko Y; Oda K; Kiyota T; Kambayashi A; Nishimura T
    Clin Pharmacol Drug Dev; 2021 Mar; 10(3):283-290. PubMed ID: 32618438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability and Pharmacokinetics of TRPV1 Antagonist Mavatrep (JNJ-39439335) Tablet and Capsule Formulations in Healthy Men: Two Open-Label, Crossover, Single-Dose Phase 1 Studies.
    Manitpisitkul P; Shalayda K; Russell L; Sanga P; Williams Y; Solanki B; Caruso J; Moyer JA
    Clin Pharmacol Drug Dev; 2018 Sep; 7(7):699-711. PubMed ID: 29125700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxcarbazepine final market image tablet formulation bioequivalence study after single administration and at steady state in healthy subjects.
    Flesch G; Tudor D; Souppart C; D'Souza J; Hossain M
    Int J Clin Pharmacol Ther; 2002 Nov; 40(11):524-32. PubMed ID: 12698990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase 1 open-label study to assess the relative bioavailability of TAK-931 tablets in reference to powder-in-capsule in patients with advanced solid tumors.
    Steeghs N; Pruis M; van Herpen C; Lu V; Redman J; Zhou X
    Invest New Drugs; 2023 Feb; 41(1):53-59. PubMed ID: 36409435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical and Clinical Pharmacokinetics and Bioavailability in Healthy Volunteers of a Novel Formulation of the Selective P2X3 Receptor Antagonist Eliapixant.
    Francke K; Chattopadhyay N; Klein S; Rottmann A; Krickau D; van de Wetering J; Friedrich C
    Eur J Drug Metab Pharmacokinet; 2023 Jan; 48(1):75-87. PubMed ID: 36469250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative fasting bioavailability of 2 bepotastine formulations in healthy male Chinese volunteers: an open-label, randomized, single-dose, 2-way crossover study.
    Shentu J; Zhou H; Hu X; Wu G; Wu L; Zhu M; Zhai Y; Zheng Y; Liu J
    Clin Ther; 2014 Apr; 36(4):579-85. PubMed ID: 24656153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative bioavailability and tolerability of a single 20-mg dose of two fluoxetine hydrochloride dispersible tablet formulations in fasting, healthy Chinese male volunteers: an open-label, randomized-sequence, two-period crossover study.
    Shi S; Liu Y; Wu J; Li Z; Zhao Y; Zhong D; Zeng F
    Clin Ther; 2010 Oct; 32(11):1977-86. PubMed ID: 21095492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effects of formulation, food, or a proton-pump inhibitor on the pharmacokinetics of glasdegib (PF-04449913) in healthy volunteers: a randomized phase I study.
    Shaik N; Hee B; Wei H; LaBadie RR
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):463-472. PubMed ID: 30536154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic comparison of sustained- and immediate-release oral formulations of cilostazol in healthy Korean subjects: a randomized, open-label, 3-part, sequential, 2-period, crossover, single-dose, food-effect, and multiple-dose study.
    Lee D; Lim LA; Jang SB; Lee YJ; Chung JY; Choi JR; Kim K; Park JW; Yoon H; Lee J; Park MS; Park K
    Clin Ther; 2011 Dec; 33(12):2038-53. PubMed ID: 22129569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers.
    Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R
    Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: an open-label, single-dose, randomized, two-way crossover study in healthy Chinese male volunteers.
    Liu Y; Jia J; Liu G; Li S; Lu C; Liu Y; Yu C
    Clin Ther; 2009 Apr; 31(4):777-83. PubMed ID: 19446150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence study of a new oral topotecan formulation, relative to the current topotecan formulation, in patients with advanced solid tumors.
    Oostendorp RL; Loftiss J; Goel S; Smith DA; Dar MM; Witteveen PO; Cohen RB; Lewis LD; Kurian S; Patnaik A; Rosing H; Beijnen JH; Voest EE; Burris H; J
    Int J Clin Pharmacol Ther; 2009 Mar; 47(3):195-206. PubMed ID: 19281729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the pharmacokinetics of the anticancer MET inhibitor foretinib free base tablet formulation to bisphosphate salt capsule formulation in patients with solid tumors.
    Naing A; Kurzrock R; Adams LM; Kleha JF; Laubscher KH; Bonate PL; Weller S; Fitzgerald C; Xu Y; LoRusso PM
    Invest New Drugs; 2012 Feb; 30(1):327-34. PubMed ID: 20842406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bioavailability comparison of generic and branded citalopram 20 mg tablets: an open-label, randomized-sequence, two-period crossover study in healthy Chinese CYP2C19 extensive metabolizers.
    Jiang T; Rong Z; Xu Y; Chen B; Xie Y; Chen C; Lu Y; Shen Y; Li H; Sun J; Chen H
    Clin Drug Investig; 2013 Jan; 33(1):1-9. PubMed ID: 23179471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence Study Comparing Fixed-Dose Combination of Clopidogrel and Aspirin with Coadministration of Individual Formulations in Chinese Subjects Under Fed Conditions: A Phase I, Open-Label, Randomized, Crossover Study.
    Li Y; Ming JE; Kong F; Yin H; Zhang L; Bai H; Liu H; Qi L; Wang Y; Xie F; Yang N; Ping C; Li Y; Chen L; Han C; Liu J; Wang X
    Adv Ther; 2020 Nov; 37(11):4660-4674. PubMed ID: 32970315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.